Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

by Freek de Haan, Wouter P.C. Boon, Chanaki Amaratunga, Arjen M. Dondorp
Published 2022

Market Formation in a Global Health Transition

by Freek de Haan, Ellen H.M. Moors, Arjen M. Dondorp, Wouter P.C. Boon
Published 2022

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

by Paulina Tindana, Freek de Haan, Chanaki Amaratunga, Mehul Dhorda, Rob W. van der Pluijm, Arjen M. Dondorp, Phaik Yeong Cheah
Published 2022

Exploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo

by Freek De Haan, Marie A. Onyamboko, Caterina I. Fanello, Charles J. Woodrow, Yoel Lubell, Wouter P.C. Boon, Arjen M. Dondorp
Published 2018

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.

by Paulina Tindana, Freek de Haan, Olugbenga Ayodeji Mokuolu, Rosemonde Guissou, Oladimeji Akeem Bolarinwa, Jean Bosco Ouedraogo, Fatoumata Tou, Wouter P.C. Boon, Ellen H.M. Moors, Arjen M. Dondorp, Mehul Dhorda, Chanaki Amaratunga, Phaik Yeong Cheah
Published 2022

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

by Freek De Haan, Oladimeji Akeem Bolarinwa, Rosemonde Guissou, Fatoumata Tou, Paulina Tindana, Wouter P.C. Boon, Ellen H.M. Moors, Phaik Yeong Cheah, Mehul Dhorda, Arjen M. Dondorp, Jean Bosco Ouedraogo, Olugbenga A. Mokuolu, Chanaki Amaratunga
Published 2022